
201 - 500 employees
Founded 2016
🧬 Biotechnology
🏥 Healthcare
💊 Pharmaceuticals
💰 $225M Series A - BlueRock Therapeutics on 2016-12
Biotechnology • Healthcare • Pharmaceuticals
BlueRock Therapeutics is a clinical-stage cell therapy company developing next-generation medicines that replace cells damaged or lost to disease. The company focuses on regenerative cell therapies with clinical programs in neurology (notably bemdaneprocel for Parkinson’s disease) and ophthalmology, and lists investigational candidates such as OpCT-001. BlueRock emphasizes transforming treatment of degenerative diseases, progressing programs through clinical trials and receiving regulatory designations (e. g. , Orphan Drug and Pioneering Regenerative Medical Product).
🔥 2 minutes ago
Associate Director guiding CMC regulatory strategy for BlueRock’s engineered cell therapies. Leading global submissions, Health Authority interactions, and regulatory plans for clinical-stage medicines.
🍂 Massachusetts – Remote
💵 $222.4k - $240k / year
💰 $225M Series A - BlueRock Therapeutics on 2016-12
⏰ Full Time
🟠 Senior
🚔 Compliance